UBS Group’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

UBS Group’s Portfolio GMVD Stock Details GMVD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,193	Closed	-$7.19K	–	11069
2022 Q4	$7.19K	Buy	+2,193	New	+$10.3K	﹤0.01%	8922
2022 Q3	–	Sell	-8	Closed	–	–	11339
2022 Q2	$0	Buy	+8	New	+$252	﹤0.01%	11331
2022 Q1	–	Sell	-200	Closed	-$12K	–	11237
2021 Q4	$12K	Buy	200 +107	+115%	+$7.98K	﹤0.01%	8605
2021 Q3	$7K	Buy	+93	New	+$9.81K	﹤0.01%	8361

Other funds holding GMVD

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

HWM

HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

UBS Group's GMVD Position: Q1 2023 in Review

UBS Group sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q1 2023, closing a stake of 2,193 shares — an estimated $7.19K sold.

UBS Group first reported a position in GMVD in Q3 2021 and held it in 4 quarters. The position peaked at $12K in Q4 2021. 9 funds tracked by Wall St. Rank hold GMVD as of Q1 2023.

UBS Group reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
UBS Group sold 2,193 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q1 2023, an estimated $7.19K.
UBS Group first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q3 2021 and held it in 4 quarters.
UBS Group's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $12K in Q4 2021.
9 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.